First PREMIER Bank’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5K Hold
100
﹤0.01% 343
2026
Q1
$4K Hold
100
﹤0.01% 354
2025
Q4
$5K Hold
100
﹤0.01% 348
2025
Q3
$6K Hold
100
﹤0.01% 362
2025
Q2
$7K Sell
100
-34
-25% -$2.31K ﹤0.01% 343
2025
Q1
$9K Sell
134
-57
-30% -$4.71K ﹤0.01% 329
2024
Q4
$16K Hold
191
﹤0.01% 291
2024
Q3
$23K Sell
191
-103
-35% -$13.7K 0.01% 279
2024
Q2
$42K Buy
294
+100
+52% +$13.3K 0.01% 222
2024
Q1
$25K Buy
+194
New +$23.1K 0.01% 254

Other funds holding NVO

First PREMIER Bank's NVO Position: Q2 2026 in Review

First PREMIER Bank held its Novo Nordisk (NVO) position steady in Q2 2026 at 100 shares worth $5K. The position accounts for ﹤0.01% of the portfolio, ranked #343.

First PREMIER Bank first reported a position in NVO in Q1 2024 and has held it in 10 quarters since. The position peaked at $42K in Q2 2024. 205 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • First PREMIER Bank held 100 shares of Novo Nordisk worth $5K as of Q2 2026.
  • First PREMIER Bank left its Novo Nordisk share count unchanged in Q2 2026.
  • Novo Nordisk made up ﹤0.01% of First PREMIER Bank's portfolio in Q2 2026, its #343 holding.
  • First PREMIER Bank first reported a position in Novo Nordisk in Q1 2024 and has held it in 10 quarters since.
  • First PREMIER Bank's Novo Nordisk position peaked at $42K in Q2 2024.
  • 205 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on First PREMIER Bank's 13F filing for Q2 2026, filed 15 Jul 2026.